Polyethylene glycol, unique among laxatives, suppresses aberrant crypt foci, by elimination of cells. by Taché, Sylviane et al.
Scandinavian Journal of Gastroenterology, 2006; 41: 730-736 
 page 1 
Author's Version 1 
 
 
 
 
 
 
 
Open Archive TOULOUSE Archive Ouverte 
(OATAO) 
OATAO is an open access repository that collects the work of Toulouse 
researchers and 
makes it freely available over the web where possible. 
 
 
This is an author-deposited version published in : http://oatao.univ-toulouse.fr/ 
Eprints ID : 641 
 
 
To link to this article :  
DOI: 10.1080/00365520500380668 
URL:http://www.ingentaconnect.com/content/apl/sgas/2006/00000041/0000000
6/art00016 
 
 
To cite this version : 
Taché, Sylviane and Parnaud, Géraldine and Van Beek, Erik and  
Corpet, Denis E. (2006) Polyethylene glycol, unique among  
laxatives, suppresses aberrant crypts foci, by elimination of  
cells. 
Scandinavian Journal of Gastroenterology, vol. 41. pp. 730-736  
.ISSN 0010-938X 
 
 
 
Scandinavian Journal of Gastroenterology, 2006; 41: 730-736 
 page 2 
Author's Version 2 
 
 
 
Polyethylene glycol, unique among laxatives, 
suppresses aberrant crypts foci, by elimination of cells 
Sylviane Taché, Géraldine Parnaud, Erik Van Beek, and Denis E. Corpet 
 
Running title:  Laxatives: PEG only suppresses ACF 
UMR Xénobiotiques, Institut National Recherche Agronomique, Ecole Nationale Vétérinaire de 
Toulouse, Toulouse, France 
 
Taché S, Parnaud G, Van Beek E, Corpet DE. Polyethylene glycol, unique among laxatives, 
suppresses aberrant crypts, by elimination of cells.  Scand J Gastroenterol xxxx 
Background: Polyethylene glycol (PEG), an osmotic laxative, is a very potent inhibitor of 
colon cancer in rats. In a search for mechanisms, we tested the hypothesis that fecal bulking 
and moisture decreases colon carcinogenesis. We also looked for PEG effects on crypt cells 
in vivo. Methods: Fischer 344 rats (N=272) were given an injection of the colon carcinogen 
azoxymethane. They were then randomized to a standard AIN76 diet containing one of 19 
laxative agents (5% w/w in most cases): PEG 8000 and other PEG-like compounds, 
carboxymethylcellulose, polyvinylpyrrolidone, sodium polyacrylate, calcium polycarbophil, 
karaya gum, psyllium, mannitol, sorbitol, lactulose, propylene glycol, magnesium hydroxide, 
sodium phosphate, bisacodyl, docusate, and paraffin oil. Aberrant crypt foci (ACF) and fecal 
values were measured blindly after a 30-day treatment. Proliferation, apoptosis, and the 
removal of cells from crypts were studied in control and PEG-fed rats by various methods, 
including TUNEL and fluorescein dextran labeling. Results: PEG 8000 reduced nine-fold the 
number of ACF in rats (p<0.001). The other PEGs and magnesium-hydroxide modestly 
suppressed ACF, but not the other laxatives. ACF number did not correlate with fecal weight 
or moisture. PEG doubled the apoptotic bodies per crypt (p<0.05), increased proliferation by 
25-50% (p<0.05) and strikingly increased (>40-fold) a fecal marker of epitheliolysis in the gut 
(p<0.001). PEG normalized the percentage of fluorescein dextran labeled cells on the top of 
ACF (p<0.001). Conclusions: Among laxatives, only PEG afforded potent chemoprevention. 
PEG protection was not due to increased fecal bulking, but likely to the elimination of cells 
from precancerous lesions. 
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Introduction 
 The prevention of colorectal cancer could employ chemopreventive agents, but known 
agents afford only modest protection. We have previously established that a diet supplemented 
with an osmotic laxative suppresses an early putative step in the development of colon cancer in 
rats (1), namely, the number of aberrant crypt foci (ACF) induced by an azoxymethane (AOM) 
injection (2). The laxative was polyethylene glycol 8000 (PEG), whose formula is H-(O-CH2-CH2)n-
OH, with n=200. PEG and PEG-like block-polymer pluronic F68 are the most potent known 
suppressors of ACF in rats (3, 4). PEG also strikingly suppresses the occurrence of AOM-induced 
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cancers in rats (5, 6). This AOM-rat model predicts the chemopreventive efficacy of dietary agents 
in humans (7). Last, a population-based study shows that PEG-based laxative users have a halved 
risk of colorectal tumors (8). 
 
 The mechanism by which PEG suppresses ACF and cancer is not known. Fecal weight 
and moisture are more than doubled in PEG-treated rats (1). Constipation, by contrast, is 
associated with increased risk of colon cancers in several case-control studies (9-11). We thus 
looked for the chemopreventive effect of several laxative agents (12). We tested seven large 
bulking polymers (MW>2000), six poorly absorbed osmotic agents (MW<400), a lubricating oil, two 
secretagogues, and three PEGs. Since many studies report the modest protective effect of wheat 
bran (13), and the promotion of carcinogenesis by anthranoid laxatives (14-16), we did not test 
them. In vitro studies suggest a second possible mechanism: PEG halts proliferation (17), induces 
apoptosis (18), and restores differentiation (19) of adenocarcinoma cells in culture. We thus sought 
a PEG effect on these functions in the colon of rats. A third hypothetical mechanism is that, like 
mucus, PEG might protect the mucosa (20). Indeed, cell membrane can reseal after being 
damaged by mechanical stress in the gut (21). Pluronic facilitates this repair process in vitro (22), 
We tested this hypothesis using fluorescein dextran (21).  
 
Materials and Methods 
General Design and Initiation of Carcinogenesis.  
 Seven sequential experiments were conducted in rats. Five 30-day studies tested the 
effect of laxative agents on AOM-induced ACF. Another 30-day study tested the effect of PEG on 
cell proliferation and apoptosis. Unless otherwise stated we used PEG 8000. One 100-day study 
made use of a fluorescent marker to see whether PEG protects or kills crypt cells. A total number 
of 272 four-week old Fisher 344 rats were obtained from Iffa-Credo (Lyon, France). They were 
acclimatized to the animal colony for one week, housed by pairs in stainless steel wire drop-bottom 
cages, in a temperature of 22 ± 2°C and with 12h/12h light and dark cycles. AIN76 diet from UAR 
(Villemoisson, France) and tap water were provided ad libitum. Each rat was given one AOM i.p. 
injection to induce ACF (20 mg/kg in saline), and randomized 7 days later to receive treatment. All 
chemicals came from Sigma (St.Quentin, France), unless stated otherwise. Body weights, food 
and water intake were monitored weekly. Daily fecal output was measured on freeze-dried feces 
collected under each cage of two rats for 24 hours. Fecal humidity was measured on fresh pellets 
obtained directly at the anus of each rat (weighed before and after freeze-drying). Thirty and seven 
days (ACF studies), or 100-130 days (fluorescent marker study) after the AOM injection, the 
animals were sacrificed by carbon dioxide asphyxiation. Investigator with French official agreement 
#31-121 handled animals, and care was in accordance with the guidelines of the European 
Council. 
Studies of Laxative Agents 
 The effect of dietary laxative agents on AOM-induced ACF was compared to the standard 
AIN76 diet (control), in five 30-day studies. They involved 32, 36 and 42 male, and 48 and 52 
female rats (no gender effect was seen). In each study some rats were randomized to a control 
group, and to a group given dietary 5% (w/w) PEG 8000 ( ICN, Orsay France). Laxative agents 
which were given to the other groups of rats were: 5% of calcium polycarbophil (brought by 7% 
Fibercon, Whitehall-Healthcare, Madison, NJ), carboxymethylcellulose (of medium viscosity, ICN), 
polyvinylpyrrolidone (MW 8000, Acros-Organics, Geel, Belgium), kaolin, karaya gum (MW 
950,000), lactulose (MW 342), mannitol (MW 182), paraffin oil (Merck, Darmstadt, Germany), PEG 
400, PEG bisphenyl A-diglycidylether (MW15,000, Aldrich, St.Quentin, France), propylene glycol 
(MW 76), psyllium (Vigan-lab., France), sorbitol (MW 182), and sodium polyacrylate (3%, MW 
8000, Aldrich), sodium phosphate (3%, 1:1 mix of NaH2PO4,2H2O:Na2HPO4,7H2O), magnesium 
hydroxide (1%), dioctyl sulfosuccinate sodium (0.3%, docusate), bisacodyl (0.01%), and piroxicam, 
a chemopreventive non laxative agent (0.04%). The end-points were the number of ACF, fecal 
weight and moisture, fecal water osmolarity, and alkaline phosphatase (ALP) activity. A single 
observer scored all colons blindly for ACF, in a randomized order, by Bird's procedure (2). Fecal 
water was obtained by adding distilled water to feces directly obtained from the anus of each rat 
(1.5 ml per 0.15 g of freeze-dried sample), and processed as previously described (1). Osmolarity 
of fecal water was measured in duplicate with freezing point depression (Roebling,; Osmomat, 
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Gonotec; Berlin, Germany). ALP is released in the fecal stream when epithelial cells are lysed (23, 
24). Intestinal ALP activity in fecal water was measured according to Lapre (24), using a specific kit 
with p-Nitrophenyl phosphate as a substrate, and L-phenylalanine as a specific inhibitor of the 
intestinal isoenzyme. That PEG did not modify ALP values was specifically checked in vitro. 
Study of PEG effect on Cell Proliferation and Apoptosis 
 Sixteen male rats received an AOM injection seven days before being randomized to a 
control group given pure water, and a treated group given 5% PEG in the drinking water for 30 
days. Sixty minutes before sacrifice each rat received an i.p. injection of 5-bromo-2’-
deoxyuridine (BrdU, 50 mg/kg in NaCl 9g/l). A 1 cm2 piece of distal colon was processed for 
histology after fixation in buffered formalin (10%). Proliferative cells in the colonic crypts were 
visualized immuno-histochemically using an anti-BrdU antibody (25). Cells in mitosis and 
apoptotic bodies per crypt were counted on 3 µm sections stained by Feulgen-fast green. 
Apoptotic bodies were recognized based on morphological identification (26). Apoptotic cells per 
crypt were also counted after Tdt-mediated dUTP-biotin nick end labeling of fragmented DNA 
(Oncogene Research Products) (25). An investigator scored 20 (proliferation) and 60 (apoptosis) 
fully visible crypts per rat in a blinded manner. 
Study of PEG Effect on Cell Resealing and Removal in Normal and Aberrant Crypts 
 Twelve rats received an AOM injection, ten rats did not. They were sacrificed 106-131 
days after initiation. Fifty hours before sacrifice, food was removed from cages. Thirty hours before 
sacrifice, all rats were given 250 mg fluorescein dextran by gavage (1 ml, MW 4400) (21). Eighteen 
hours before sacrifice ten rats were allowed to drink water with 5% PEG, and twelve rats were 
given pure water (see Table I). Colons were prepared as they had been for ACF. Fluorescein-
labeled cells, and nuclei (to estimate total number of cells) were then counted in 100 normal and 60 
aberrant crypts at 400 x magnification with a fluorescence microscope (Axiolab, Zeiss).  
Statistical Methods 
 Group means were compared by Student's t test, or by Welch's t test when variances were 
not equal, or by Mann-Whitney test when data were not normally distributed. To compare many 
treated groups to a single control group, the Dunnett's test was used when Bartlett's statistics 
showed non-significant differences among variances. A non-parametric Kruskal-Wallis was used in 
other cases. Standard deviations (SD) are reported in the text, and pooled standard error of the 
mean (SEM) in Table 1. All P values quoted correspond to two-tailed test, and P value below 0.05 
was considered significant. 
 Results 
The Effect of 19 Laxative Agents on AOM-induced ACF, and on Fecal Values 
 Five independent short-term studies were conducted to test the hypothesis that laxative 
drugs can decrease the number of ACF during the post-initiation period. The results are shown on 
Figure 1, using the ACF values in control rats to normalize data across the five studies (full data not 
shown). PEG, unique among laxative agents, strikingly suppressed ACF. Compared to control rats, 
PEG-treated rats had a nine-fold reduction in the number of ACF and a 13-fold reduction in the 
number of large ACF (mean of 5 studies, all p<0.001). Other PEGs also reduced the number of 
ACF, but to a lower extent. PEG 400 was roughly half as potent as PEG 8000, as previously shown 
for PEG 3350 (6). Other laxatives did not reduce significantly the number of ACF (Figure 1) except 
magnesium hydroxide. In bisacodyl-fed rats all crypts looked aberrant and colons could not be 
scored for ACF, but small tumors were detected (N=0.8/rat). Rats treated with the non-laxative 
NSAID piroxicam had significantly less ACF than controls (p<0.001), but  twice more ACF than 
PEG-treated rats. 
 Laxative polymers of high MW, including PEGs, roughly doubled both the daily fecal output 
(dry weight) and the fecal moisture (Figure 2, full data not shown). The rats consumed and 
excreted about 1 g of PEG per day, which explains the increased fecal weight. Small MW agents 
had less effect on fecal values in rats, except magnesium hydroxide (doubled fecal moisture), 
kaolin and paraffin oil (doubled fecal dry weight). Karaya gum, carboxymethylcellulose, 
polyvinylpyrrolidone and PEG were thus potent laxatives in rats (Figure 2), but only PEG 8000 
strongly reduced the ACF number (Figure 1). This suggests that the ACF inhibition by PEG 8000 
was not due solely to its fecal bulking activity. Indeed, a modest inverse correlation was found 
between the ACF number in the colon of rats and fecal dry weight and fecal moisture. The 
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correlation coefficients were -0.40 and -0.53 respectively (p<0.05, d.f. 25). However, after exclusion 
of PEG data, the ACF number did not correlate any longer with fecal dry weight or with fecal 
moisture. 
 In vitro data suggest that cytostatic effect of PEG on cell lines be due to PEG-induced 
osmotic pressure (17). Osmolarity of fecal water from all rats was thus measured, but it was not 
changed by PEG or by laxative treatments (p>0.05), and it did not correlate with ACF numbers 
(data not shown). These results show that PEG-prevention of carcinogenesis is not due to laxative 
effect, or to osmotic properties of PEG.  
PEG Increased Crypt Cells Apoptosis and Proliferation 
 Apoptosis, an important prevention mechanism (25), was measured by two different 
techniques in 3 µm sections of colonic mucosa from control and PEG-treated rats. The number of 
apoptotic bodies was doubled in PEG-treated rats compared with controls. After a 30-day PEG-
treatment of AOM-initiated rats, the number of apoptotic bodies per crypt scored on Feulgen-fast 
green stained sections increased from 0.05 ± 0.03 to 0.12 ± 0.04 (p=0.002). In a distinct 
experiment, the TUNEL labeled cells per crypt increased from 0.05 ± 0.02 in controls to 0.08 ± 0.03 
in PEG-treated rats (p=0.04). In addition, PEG strikingly increased the ALP activity in feces (25-fold 
increase, per g of dry feces), and daily fecal excretion of ALP (44-fold increase, median of five 
studies). In one study, for instance, control and PEG-treated rats excreted 98 ± 34 and 4158 ± 
1765 Sigma ALP Units/d respectively (p<0.001). Intestinal ALP activity in fecal water would reflect 
epitheliolysis (23, 24). Thus, PEG clearly enhanced apoptosis and epitheliolysis in the mucosa.  
 Crypt lengthening and cell proliferation are often associated with colon carcinogenesis 
(27). We thus speculated that PEG-prevention might be associated with crypt shortening and 
reduced cell proliferation. After a 30-day PEG-treatment in AOM-initiated rats, crypt height was 
reduced from 32.3 ± 2.6 cells in controls to 27.3 ± 2.9 in PEG-fed rats (p<0.01). But PEG 
surprisingly increased crypt cell proliferation. The BrdU labeled cells per crypt increased from 3.12 
± 0.58 in controls to 3.99 ± 0.63 in PEG-treated rats (p<0.01). Also, the number of mitoses per 
crypt increased from 0.35 ± 0.19 to 0.53 ± 0.11 (p=0.03). A duplicated study showed similar 
reduction of crypt length (p<0.01), and increased proliferation (p=0.04) after a 7-day PEG-
treatment. 
 PEG Removed Cells on Top of Aberrant Crypts 
 Fluorescein dextran labeled cells were easily counted on top of normal and aberrant crypts 
(Figure 3). Twice more labeled cells were counted per AOM-initiated aberrant crypt cells, than per 
normal crypt cells (Table I, 12.5 and 5.4 cells respectively, p<0.001). According to McNeil, this 
might suggest that transformed cells on top of ACF are more fragile, or more exposed to 
mechanical stress, than normal crypt cells (21). After fluorescent labeling, an 18-hour PEG-
treatment normalized the proportion of fluorescent cells in aberrant crypts: the percentage of 
labeled cells on ACF decreased from 12.5 to 7.0 % (p<0.001), which shows that PEG eliminated 
cells from ACF. Indeed, PEG-treatment slightly reduced total number of cells seen in ACF, from 42 
to 38 cells per crypt (p<0.001). PEG-treatment also slightly decreased the percentage of labeled 
cells in normal crypts, from 5.4 to 4.0 (p<0.01). 
Discussion 
 This study demonstrates that (i) among 19 laxatives, only PEG 8000 and its analogs were 
potent chemopreventive agents against colon carcinogenesis in a rat model, (ii) the mechanism of 
PEG protection was not related to increased fecal bulking or water content, (iii) PEG induced 
proliferation, epitheliosyis, and apoptosis in colonic crypts, which confirms Roy's findings (28), and 
(iv) PEG seems to remove damaged cells from the top of ACF.  
 The results show that a 30-day PEG-treatment reduced 9-fold the number of ACF, and 13-
fold the number of large ACF (mean of 5 studies, all p<0.001). Previous studies have shown the 
following facts: Following a 105-day PEG-treatment rats have 20-times less ACF and 100 times 
less large ACF than controls (1). PEG is more potent than most known preventive agents in this rat 
model (3), and the effect is not limited to a specific carcinogen, since hydrazine, nitrosamine, and 
heterocyclic amine-induced ACF are suppressed (6). PEG effect is fast: a three-day PEG-
treatment, one month after carcinogen injection, halves the number of ACF in rats (6).  
  The mechanism by which PEG can prevent carcinogenesis in rats is not known. 
Speculated mechanisms include (i) dilution of promoting compounds in the gut lumen due to PEG 
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osmotic and bulking properties, (ii) protection of epithelia by PEG lubricating, coating, and sealing 
properties, (iii) elimination of cancer cells from the tumors by apoptosis induction. These three 
hypotheses are discussed here: 
 (i) High-molecular weight PEGs are not absorbed from the gut of rats and bind water 
through hydrogen bonding (29). In PEG-fed rats, the fecal weight and moisture increased markedly 
(fig.2), and we have shown that the concentration of bile acids in fecal water is halved (1). 
However, the present study clearly shows that this bulking effect does not explain the anti-cancer 
properties of PEG. Indeed, some laxatives increased both fecal dry weight and fecal moisture as 
much as PEG, but they did not reduce ACF (e.g., karaya gum). Previous studies show that psyllium 
and wheat bran can double the fecal bulk, but only modestly suppress ACF (3).  Magnesium 
hydroxide also showed some protective effect here. Magnesium is a known chemopreventive 
agent (30-32). It may act like calcium, unrelated with laxative properties (33, 34). Small tumors 
were detected in bisacodyl-fed rats only one month after AOM injection, thus confirming it is a 
strong tumor promoter (15). To conclude, because bulking does not cause chemoprevention, it 
should be possible to design PEG-like chemopreventive agents with no laxative effect. 
 (ii) Alternatively, PEG may protect the colonic mucosa by lubricating the fecal stream (29), 
by providing a mucin-like barrier and reducing inflammation (20), or by facilitating the membrane 
resealing (21), thus reducing the ACF over-proliferation. This hypothesis is supported by our in vitro 
data (17) and by the strong chemoprevention afforded by pluronic (4), a PEG-like agent that binds 
membranes and repairs cell membrane defects (22). In contrast, this study clearly shows that PEG 
increased proliferation, like aspirin and sulindac (35, 36). PEG also appears to increase the turn-
over of cells on top of ACF crypts (table I), and greatly increased fecal ALP, a potential marker of 
epitheliolysis (23, 24). In addition, while a 0.05% PEG concentration protects cells in vitro (37), a 
100-times higher concentration is needed to suppress ACF in vivo (5). 
 (iii) Lastly, according to in vitro results, PEG might eliminate transformed cells by apoptosis 
(17, 18). This would normalize or "erase" ACF, explaining the fast loss of ACF (6). Indeed, PEG-
treatment doubled the number of apoptotic bodies in colonic crypts, as recently reported in ACF 
and in Min mice (28). This could be meaningful because a fish oil and pectin diet that increases 
apoptotic index by +25% decreases adenocarcinoma incidence by -50% in rats (25). In addition 
PEG strikingly increased epitheliolysis in the gut, increased proliferation but reduced crypt length, 
and halved the number of labeled cells on top of ACF (table I). Taken together, these facts suggest 
that PEG has an abrasive effect on the mucosa. How could abrasion be protective? Although it is 
highly controversial, the elimination of cells from the top of crypts might be enough to stop 
carcinogenesis, by preventing the top-down movement of transformed cells (38). This would 
explain why the inhibition was reversible in part when treatment was discontinued (6). Similarly, 
chemical peeling with PEG and salicylic acid strikingly suppresses skin tumor development in mice 
(39).  
 The present study is not definitive, and following questions might still be addressed: (i) Do 
non-protective laxatives induce apoptosis and epitheliolysis? (ii) We suggest that PEG removes 
cells from ACF, that often hold K-ras mutation. The DNA of shedded cells can be detected in stools 
(40). So, does PEG increase fecal flow of K-ras mutations? (iii) How could PEG induce apoptosis 
and epitheliolysis? Added into a culture medium, PEG increases the osmotic pressure and shrinks 
cancer cells (17). By contrast, in vivo, PEG drags water into the gut lumen, which in turn balances 
the osmotic pressure (29). Thus, PEG-effect is not due to osmotic pressure, but might be due to 
detergent properties. Indeed, PEG induces cell fusion in vitro, accumulates in cancer cells, and the 
optimal MW to enhance endocytosis and to suppress ACF is identical, i.e., 8000 (6, 41). Last, 
PEG-induced apoptosis may come from the modulation of transcription factors, e.g., induction of 
pro-apoptotic factor Par-4, and suppression of E-cadherin down-regulating factor SNAIL (18, 42).  
 To conclude, data suggest that PEG acts by eliminating cells from ACF. PEG is used as a 
mild laxative at a dose which matches the dose used in rats (43). A recent population-based study 
of 1165 colonoscopies in France shows that Forlax® users (a PEG 4000-based laxative) have a 
halved risk of colorectal tumors (8). High MW PEGs have no known toxicity, are not absorbed, not 
metabolized, and not fermented. We thus suggest PEG be tested in a clinical trial. 
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Figure 1: Among 19 laxative agents, PEG only strongly suppressed carcinogenesis in AOM-
initiated rats.  
 
Fischer rats (N=210) were given an injection of azoxymethane. They were then randomized to a 
standard AIN76 diet containing one of 19 laxative agents (5% w/w in most cases). Aberrant crypt 
foci (ACF) were measured blindly after a 30-day treatment. Results from five sequential studies are 
shown after normalizing values to 100 for each control groups.  
 
Area of circles matches groups’ size (large: 12 rats; small: 4 rats). Overlapping points were shifted 
to be more visible. Star indicates results different from control (Dunnet’s test). Unnamed small 
points: m: mannitol, l: lactulose, p: psyllium, o: paraffin oil, s: sorbitol, k: kaolin. Actual values of 
ACF (and of aberrant crypts) in the 5 control groups were 53 (119), 62 (139), 96 (200), 122 (264), 
80 (172). Matching values in PEG-fed rats were 4 (8), 5 (8), 2 (6), 22 (39), 13 (23). Piroxicam 
and bisacodyl results are not shown on this figure (see text). 
 
Scandinavian Journal of Gastroenterology, 2006; 41: 730-736 
 page 12 
Author's Version 12 
70
90
110
130
150
170
190
210
230
80 100 120 140 160 180 200 220
Fecal moisture (percent control)
Fe
c
a
l d
ry
 
w
ei
gh
t /
da
y 
/ra
t (%
 
co
n
tr
o
l)
controls PEGs high MW low MW
PEG#
PEG#
 5 controls 
carboxymethyl-
cellulose#
PEG400#
PEG-bis-
phenyl#
MgOH*
karaya gum#
polyvinyl-
pyrrolidone#
Na polyacrylate* 
propylene glycol
kaolin*
paraffin  oil*
psyllium*
bisacodyl*
Na phosphate
PEG#
PEG#
Ca polycarbophil*
PEG#
m
s
d
l
 
 
Figure 2: High MW laxative agents increased the daily fecal excretion (dry weight) and the 
fecal moisture (percent water) in rats fed a purified diet for one month.  
 
Design: see figure 1. *: different from control for fecal excretion or moisture; #: different from control 
for fecal excretion and moisture (Dunnet’s test). Unnamed small points (near controls): m: 
mannitol, s: sorbitol, d: docusate, l: lactulose. Actual values of fecal moisture given as % water (and 
fecal dry weight, g/d) in the 5 control groups were 30 (0.85), 45 (0.69), 41 (0.78), 45 (1.16), 44 
(1.26). Matching values in PEG-fed rats were 68 (1.73), 68 (1.37), 69 (1.40), 66 (1.88), 68 (2.16).  
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Figure 3: Fluorescein dextran labeled cells on top of a four-crypt ACF.  
 
Fluorescence micrograph of colon mucosa (magnification x 400). The rat was sacrificed 130 d after 
an AOM injection, and 30 h after a 250 mg fluorescein dextran gavage (this rat did not receive 
PEG).  
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Table I: An 18-hour PEG-treatment normalizes the proportion of cells labeled by fluorescein 
dextran on top of aberrant crypts, 105-130 days after an injection of carcinogen AOM to rats and 30 
h after a 250 mg fluorescein dextran gavage. 
 
 Rat 
Treatment 
No. of 
rats 
No. of crypts 
scored 
Cells seen 
per crypt 
Labeled cells  
per crypt 
Mean percent  
of labeled cells 
 
Normal  
Crypts 
none 6 620 14.8 0.84 5.4 
 PEG 4 460 15.2 0.67 4.0 * 
 AOM 6 600 14.9 1.02 ** 6.6 
 AOM + PEG 6 680 14.8 0.66 4.1 ** 
SEM    0.1 0.04 0.25 
ACF  
Crypts 
AOM 6 350 42.4 5.64 12.5 
 AOM + PEG 6 405 38.1 ** 2.91 ** 7.0 ** 
SEM    0.7 0.2 0.4 
 
Notes to Table I. SEM: pooled standard error of the mean; ** p<0.001; * p<0.01; Dunnet's test 
(normal crypts, comparison with "none" group) or Student’s test (ACF crypts, comparison with 
"AOM" group).  
